Navigation Links
Aubrey Inc. Releases New Advanced Biosynthetic Wound Care Product 'AWBAT Plus'
Date:1/20/2011

CARLSBAD, Calif., Jan. 20, 2011 /PRNewswire/ -- Aubrey Inc. – http://www.aubreyinc.com – announced that after a successful soft release and product evaluation phase of its second generation product, AWBAT® Plus, it is now in full production and currently available for purchase.  Founder Aubrey Woodroof, PhD MBA, expresses his appreciation for being able to advance the art once again.  "It is a wonderful feeling to hear from a renowned surgeon that 'AWBAT® Plus has the potential to take wound coverage to the next level' and that it 'provides not only an optimal milieu but also a stimulus to promote active wound healing.'"

AWBAT® Plus utilizes the same patented technology for the precision-porous silicone-nylon membrane as the platform product, AWBAT®.  AWBAT® Plus, however, contains not only significantly more collagen but also chondroitin-4-sulfate, chondroitin-6-sulfate, vitamin C, vitamin E and Immuno-10 (activated mixture of polysaccharides from Aloe).  It was determined by FDA to be a combination product consisting of device components as well as drugs.  In subsequent laboratory testing, Immuno-10 was found to stimulate human dermal fibroblast proliferation, as well as fibroblast collagen and alpha-SMA production.  Human keratinocyte production was also enhanced by Immuno-10.  AWBAT® Plus is currently indicated for partial thickness burns, meshed autografts, and donor sites.

Woodroof stated: "We are very excited to have AWBAT® Plus now also available in our proprietary glove design.  Hand burns are common injuries and complex wounds to treat. The AWBAT® Plus Glove was designed specifically for ease of application and form fit, and to promote early mobility and rehabilitation, which is essential for maintaining functional dexterity and faster return to work."

Aubrey Inc. intends to seek clearance for use of AWBAT® Plus on chronic wounds this year.  Woodroof noted that in an investigator initiated evaluation of AWBAT® Plus on chronic wounds, the surgeon stated, "We have found AWBAT®-D Plus to be an effective alternative to Apligraf®, Dermagraft® and Integra® in preliminary observations of chronic wound management.  AWBAT®-D Plus can be used as an adjunct with NPWT."

About Aubrey Inc.

Dr. Aubrey Woodroof invented Biobrane® in 1978, an innovative product which revolutionized burn care.  In 2007, Woodroof came out of retirement to create the AWBAT® line as the next generation of advanced wound care technology.


'/>"/>
SOURCE Aubrey Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. CEL-SCI Corporation Releases Letter to Shareholders
3. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. Immunosyn Corporation Releases SF-1019 Study Results
6. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
8. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
9. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
10. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
11. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, Inc. ... on providing the Urology, Uro/Gyn and Gynecology markets ... Ash Keswani has joined the Company as Senior ... newly created position, Mr. Keswani will report directly ... "Our organization is delighted that Ash ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... typically been previously exposed to more adverse experiences than children in the general ... trauma such as abuse, neglect or other family challenges. While no fault of ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to accept that hearing ... aid doesn’t have the stigma it had when great-grandpa wore his hearing aids years ... in a NALA North American Speaker Series (NASS) segment. “He probably wore ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... which name the Creator responds to and which He does not. Yisrayl says with ... which one is the true name, but he says with a little Scripture, backed with ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA is pleased to ... 20+ years of experience within the beauty industry, ranging from marketing, retail support, ... high-end cosmetic brands, retail brands and outlets in Canada and New York. As ...
Breaking Medicine News(10 mins):